Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36077307)

  • 1. Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin Lymphoma.
    Repetto O; Caggiari L; De Zorzi M; Elia C; Mussolin L; Buffardi S; Pillon M; Muggeo P; Casini T; Steffan A; Mauz-Körholz C; Mascarin M; De Re V
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Profiles and Biological Processes of Relapsed vs. Non-Relapsed Pediatric Hodgkin Lymphoma.
    Repetto O; De Re V; Mussolin L; Tedeschi M; Elia C; Bianchi M; Buffardi S; Sala A; Burnelli R; Mascarin M
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32235718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence.
    Repetto O; Lovisa F; Elia C; Enderle D; Romanato F; Buffardi S; Sala A; Pillon M; Steffan A; Burnelli R; Mussolin L; Mascarin M; De Re V
    Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34063765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Identification of Plasma Biomarkers in Children and Adolescents with Recurrent Hodgkin Lymphoma.
    Repetto O; Mussolin L; Elia C; Martina L; Bianchi M; Buffardi S; Sala A; Burnelli R; Mascarin M; De Re V
    J Cancer; 2018; 9(24):4650-4658. PubMed ID: 30588249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
    Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
    BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomics profiling of plasma from children with asthma.
    Zhou Y; Kuai S; Pan R; Li Q; Zhang J; Gu X; Ren H; Cui Y
    Int Immunopharmacol; 2023 Jun; 119():110249. PubMed ID: 37146352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.
    Gharbaran R; Goy A; Tanaka T; Park J; Kim C; Hasan N; Vemulapalli S; Sarojini S; Tuluc M; Nalley K; Bhattacharyya P; Pecora A; Suh KS
    J Hematol Oncol; 2013 Aug; 6():62. PubMed ID: 23988031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum complement proteomics reveal biomarkers for hypertension disorder of pregnancy and the potential role of Clusterin.
    Zeng S; Han M; Jiang M; Liu F; Hu Y; Long Y; Zhu C; Zeng F; Gan Q; Ye W; Fu W; Yang H
    Reprod Biol Endocrinol; 2021 Apr; 19(1):56. PubMed ID: 33874952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset.
    Metz TO; Qian WJ; Jacobs JM; Gritsenko MA; Moore RJ; Polpitiya AD; Monroe ME; Camp DG; Mueller PW; Smith RD
    J Proteome Res; 2008 Feb; 7(2):698-707. PubMed ID: 18092746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline plasma proteomic analysis to identify biomarkers that predict radiation-induced lung toxicity in patients receiving radiation for non-small cell lung cancer.
    Cai XW; Shedden KA; Yuan SH; Davis MA; Xu LY; Xie CY; Fu XL; Lawrence TS; Lubman DM; Kong FM
    J Thorac Oncol; 2011 Jun; 6(6):1073-8. PubMed ID: 21532507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma proteomic analysis reveals altered protein abundances in HIV-infected patients with or without non-Hodgkin lymphoma.
    Zhuang K; Zhang Y; Mo P; Deng L; Jiang Y; Yu L; Mei F; Huang S; Chen X; Yan Y; Tang H; Li X; Xiong Y; Wu S; Ke H; Gui X; Lan K
    J Med Virol; 2022 Aug; 94(8):3876-3889. PubMed ID: 35415847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of pathway biomarkers from coupled proteomics and systems biology methods.
    Zhang F; Chen JY
    BMC Genomics; 2010 Nov; 11 Suppl 2(Suppl 2):S12. PubMed ID: 21047379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma proteomic analysis may identify new markers for radiation-induced lung toxicity in patients with non-small-cell lung cancer.
    Cai XW; Shedden K; Ao X; Davis M; Fu XL; Lawrence TS; Lubman DM; Kong FM
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):867-76. PubMed ID: 20510197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-expression profiles in mouse blood-plasma following acute whole-body exposure to (137)Cs gamma rays.
    Rithidech KN; Honikel L; Rieger R; Xie W; Fischer T; Simon SR
    Int J Radiat Biol; 2009 May; 85(5):432-47. PubMed ID: 19365744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene A
    Ma TT; Cao MD; Yu RL; Shi HY; Yan WJ; Liu JG; Pan C; Sun J; Wei QY; Wang DY; Wei JF; Wang XY; Yin JS
    Front Immunol; 2020; 11():559746. PubMed ID: 33329520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma-Based Proteomics Profiling of Patients with Hyperthyroidism after Antithyroid Treatment.
    Masood A; Benabdelkamel H; Ekhzaimy AA; Alfadda AA
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32575434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric classical Hodgkin lymphoma.
    Lo AC; Dieckmann K; Pelz T; Gallop-Evans E; Engenhart-Cabillic R; Vordermark D; Kelly KM; Schwartz CL; Constine LS; Roberts K; Hodgson D
    Pediatr Blood Cancer; 2021 May; 68 Suppl 2():e28562. PubMed ID: 33818890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma-derived Extracellular Vesicles Contain Predictive Biomarkers and Potential Therapeutic Targets for Myocardial Ischemic (MI) Injury.
    Cheow ES; Cheng WC; Lee CN; de Kleijn D; Sorokin V; Sze SK
    Mol Cell Proteomics; 2016 Aug; 15(8):2628-40. PubMed ID: 27234505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery and identification of a candidate proteomic biomarker of active tuberculosis.
    Liu J; Jiang T; Wei L; Yang X; Wang C; Zhang X; Xu D; Chen Z; Yang F; Li JC
    BMC Infect Dis; 2013 Oct; 13():506. PubMed ID: 24168695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.